Total Funding
60
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
173652
Endo develops and markets generics and branded medications for patient care.
David James: National Account - Senior Director of Specialty TradePast Role: Vastech, Co-Founder- Phil Procker: Vice President & Chief Information Security Officer
About the Company
Endo is a pharmaceutical company that develops and manufactures generics and branded medications for various medical needs, focusing on therapeutic areas such as pain management, urology, and endocrinology. The company offers a range of products, including prescription medications and over-the-counter treatments, aimed at addressing conditions like
chronic pain, hormone-related disorders, and other health issues. Endo also engages in research and development to expand its portfolio and improve patient outcomes through innovative therapeutic solutions.
